Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo

被引:219
作者
Nguyen, A
Burack, WR
Stock, JL
Kortum, R
Chaika, OV
Afkarian, M
Muller, WJ
Murphy, KM
Morrison, DK
Lewis, RE
McNeish, J
Shaw, AS
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA
[3] Pfizer Inc, Cent Res, Dept Exploratory Med Sci, Groton, CT 06340 USA
[4] Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
[5] McMaster Univ, Dept Biol, Inst Mol Biol & Biotechnol, Hamilton, ON L8S 4K1, Canada
[6] NCI, Frederick Canc Res & Dev Ctr, Regulat Cell Growth Lab, Frederick, MD 21702 USA
关键词
D O I
10.1128/MCB.22.9.3035-3045.2002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
While scaffold proteins are thought to be key components of signaling pathways, their exact function is unknown. By preassembling multiple components of signaling cascades, scaffolds are predicted to influence the efficiency and/or specificity of signaling events. Here we analyze a potential scaffold of the Ras/mitogenactivated protein kinase (MAPK) pathway, kinase suppressor of Ras (KSR), by generating KSR-deficient mice. KSR-deficient mice were grossly normal even though ERK kinase activation was attenuated to a degree sufficient to block T-cell activation and inhibit tumor development. Consistent with its role as a scaffold, high-molecular-weight complexes containing KSR, MEK, and ERK were lost in the absence of KSR. This demonstrates that KSR is a bona fide scaffold that is not required for but enhances signaling via the Ras/MAPK signaling pathway.
引用
收藏
页码:3035 / 3045
页数:11
相关论文
共 73 条
[1]   Positive and negative selection invoke distinct signaling pathways [J].
AlberolaIla, J ;
Hogquist, KA ;
Swan, KA ;
Bevan, MJ ;
Perlmutter, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :9-18
[2]   SELECTIVE REQUIREMENT FOR MAP KINASE ACTIVATION IN THYMOCYTE DIFFERENTIATION [J].
ALBEROLAILA, J ;
FORBUSH, KA ;
SEGER, R ;
KREBS, EG ;
PERLMUTTER, RM .
NATURE, 1995, 373 (6515) :620-623
[3]   Anti-apoptotic signaling by a colony-stimulating factor-1 receptor insulin receptor chimera with a juxtamembrane deletion [J].
Boehm, JE ;
Chaika, OV ;
Lewis, RE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :7169-7176
[4]  
BUBENIK J, 1984, NEOPLASMA, V31, P497
[5]   Signal transduction: hanging on a scaffold [J].
Burack, WR ;
Shaw, AS .
CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (02) :211-216
[6]  
Cacace AM, 1999, MOL CELL BIOL, V19, P229
[7]   Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation [J].
Cheng, AM ;
Saxton, TM ;
Sakai, R ;
Kulkarni, S ;
Mbamalu, G ;
Vogel, W ;
Tortorice, CG ;
Cardiff, RD ;
Cross, JC ;
Muller, WJ ;
Pawson, T .
CELL, 1998, 95 (06) :793-803
[8]   The MAP kinase pathway controls differentiation from double-negative to double-positive thymocyte [J].
Crompton, T ;
Gilmour, KC ;
Owen, MJ .
CELL, 1996, 86 (02) :243-251
[9]   Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1 [J].
Cuenda, A ;
Dorow, DS .
BIOCHEMICAL JOURNAL, 1998, 333 :11-15
[10]   Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252